Tags for This Article:

USA United States Of America (7178)  United Kingdom (852)  Canada (755)  Ohio (754)  OpEdNews (558)  United Kingdom England (507)  Lawsuits (478)  Australia (380)  Law-Legal-Torts (319)  Alaska (271)  Press Release (261)  Drug Companies- Marketing (203)  Health Psychology-Mental Health (186)  New Zealand (137)  Corporations Pharmaceuticals (120)  Health Care Liability (109)  United Kingdom Scotland (100)  Health Drugs (91)  Health Psychiatry (76)  United Kingdom Wales (67)  Canada British Columbia (28) 

Populum Tag Cloud
       Control Panel
Fine tune your search to access content
Articles
Diaries Products
Events All
All time
Last 6 mos
Last month
Last week
Last 24 hrs
From:
Month  Day   Year

To:
Month  Day   Year
Alphabet
Popularity
Count ON
Count OFF
This Level
Sub-levels

 

 

 

Tag(s): ; ; ; ; ; ; ; ; ; ; (more...) ; ; ; ; ; ; ; ; ; ;  (less...)
Add to My Group
October 2, 2006 at 20:54:41

Zyprexa Takes Major Hit In Alaska

by Evelyn Pringle     Page 1 of 5 page(s)

www.opednews.com

 
Tell A Friend

View Ratings | Rate It  

A major legal victory recently occurred in the highest court in the state of Alaska, for all people who oppose forced psychiatric drugging. In a resounding affirmation of personal liberty, the Alaska Supreme Court issued a decision in the case of Myers v Alaska Psychiatric Institute and found Alaska's forced drugging regime to be unconstitutional.

One of the drugs that the Institute tried to force on the plaintiff was Zyprexa and from here on in, the state cannot force people to take Zyprexa, or any other psychiatric drug, without first proving it to be in the patient's best interests and that there are no less restrictive alternatives available. The ruling is specific to psychiatric drugs.



"By requiring the least intrusive alternative to forced psychiatric drugging," says Jim Gottstein, the triumphant attorney in the case, "this decision has the potential to change the face of current psychiatric practice, dramatically improving the lives of people who now find themselves at the wrong end of a hypodermic needle."

Mr Gottstein acknowledges that the ruling will effect drug company profits. "The issue of Big Pharma profits is a big one, of course," he says, "and the Myers decision is perhaps most relevant where it states, "a valid debate exists in the medical/psychiatric community as to the safety and effectiveness of the [drugs]."

"This is judicial confirmation," he explains, "that the safety and efficacy of these psychiatric drugs has not really been established and can be used to support that contention."

"Most importantly in my mind," Mr Gottstein continued, "is that if the Myers stricture that people can't be forced to take these unwanted drugs if there are less restrictive alternatives results in these non-drug approaches being used, that will directly cut down on their use. "

"The key ruling that I think can be used to benefit other people who are faced with forced drugging," he advises, "is that under the Myers decision the state can't force drug people if there is a less restrictive alternative."

"This can be used to require that such alternatives be supported," he added.

"While the Supreme Court ruling is only binding in Alaska," says patient advocate, Vince Boem, "the ruling can be cited as persuasive authority in other states, and the legal theories involved can serve as a road map for attorneys arguing similar cases."

Faith Myers, the plaintiff in the case, said of the decision, "It makes all of my suffering worthwhile."

While acknowledging that some people find psychiatric drugs helpful, Mr Gottstein said he pursued this case because, in addition to the drugs' serious physical health risks, he is concerned about the rights of those who find the drugs both unhelpful and intolerable.

"No other field of medicine allows this sort of forced treatment," he points out.

"For people who want to try non-drug approaches," he explains, "the research is very clear that many will have much better long-term outcomes, including complete recovery after being diagnosed with serious mental illness."

"This decision restores the rights of those people to pursue that potential," he states.

"Of course," he says, "there are many people who see psychiatrists and voluntarily, even eagerly, take psychiatric medications."

And he "has absolutely no complaint about this," he states.

 1  |  2  |  3  |  4  |  5

 

Evelyn Pringle is a columnist for OpEd News and investigative journalist focused on exposing corruption in government and corporate America.

Contact Author
Contact Editor
View Other Articles by Author

 

Bookmark this page: (what's this?)

NETSCAPE      DIGG THIS      Add This Page to Mr Wong!           NEWSVINE      DEl.ICIO.US      Looksmart Furl      My Web      Tag!RawSugar      Blink List     (More...)
Comments: Expand   Shrink   Hide  
2 comments

Danny Haszard Bangor Maine Counter-cult educator
Danny HaszardDanny Haszard Bangor Maine Counter-cult educator

Eli Lilly in the news

Eli Lilly 3Q 10% profit rise is nearly all from psyche drugs including zyprexa.

How have they schemed to squeeze more money from their zyprexa cash cow when pill production has actually gone down?

ANS-Eli Lilly profiteers have jacked up the price of zyprexa to the federal govt,from the Medicare D payouts.

Eli Lilly is a big drug company that puts profits over patients.

They covered up findings that their Zyprexa has a TEN times greater risk of causing type 2 diabetes

Only 9% of Americans trust big pharma,right around the same rating as tobacco companies.

Daniel Haszard ~ Eli Lilly zyprexa drug caused my diabetes~ www.zyprexa-victims.com

by Danny Haszard (2 articles, 0 quicklinks, 0 diaries, 53 comments) on Saturday, October 21, 2006 at 5:10:11 AM
 


Danny Haszard Bangor Maine Counter-cult educator
Danny HaszardDanny Haszard Bangor Maine Counter-cult educator

Expensive Zyprexa ineffective for many

I took zyprexa which was ineffective for my condition and gave me diabetes.

Zyprexa, which is used for the treatment of psychiatric disorders, such as schizophrenia and bipolar disorder, accounted for 32% of Eli Lilly's $14.6 billion revenue last year.

Zyprexa is the product name for Olanzapine,it is Lilly's top selling drug.It was approved by the FDA in 1996 ,an 'atypical' antipsychotic a newer class of drugs without the motor side effects of the older Thorazine.Zyprexa has been linked to causing diabetes and pancreatitis.

Did you know that Lilly made nearly $3 billion last year on diabetic meds, Actos,Humulin and Byetta?

Yes! They sell a drug that can cause diabetes and then turn a profit on the drugs that treat the condition that they may have caused in the first place!

I was prescribed Zyprexa from 1996 until 2000.
In early 2000 i was shocked to have an A1C test result of 13.9 (normal is 4-6) I have no history of diabetes in my family.
----
Daniel Haszard http://www.zyprexa-victims.com

by Danny Haszard (2 articles, 0 quicklinks, 0 diaries, 53 comments) on Tuesday, October 3, 2006 at 9:25:25 AM
 

 

2 comments

 

Tell A Friend

 


Copyright © OpEdNews, 2002-2008

Blog Ads

 

 

 

 

Most Popular Articles
in the Last 2 Days
(by Recommend Emails)

Keith Olbermann Broke Up With Me! by Shannyn Moore

Children dying in Haiti, victims of food crisis exacerbated by four devastating tropical storms Posted by Stephen Fox

Study Confirms Genetically Modified Crops Threaten Human Fertility and Health Safety Posted by sadelaine

Surviving an Economic Crash: Resources and Tips by Kathryn Smith

SO SAY THE BANKERS: Learn to Love the 'AMERO' by Patrick Henningsen

A Turkey By Any Other Name--Is Still the Governor of Alaska by Brasch

Home Depot Founder: Retailers Who Don't Support GOP "Should Be Shot" Posted by Joan Brunwasser

Congress Opposes Bush Pardons by David Swanson

Fate of Lakotahs Highlights America's Failed Native American Policies by Stephen Lendman

Senate testimony by police captain reveals 9 sticks of missing dynamite in 'Omaha Two' bombing case by Michael Richardson

Go To Top 50 Most Popular